Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBust-ERTM, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy.
Cerevast was formed in September of 2009 following the acquisition of substantially all of the assets of ImaRx Therapeutics, Inc. – a publicly traded company focused on the development of microsphere contrast agents and therapeutics. Through this acquisition, Cerevast gained title to the dominant intellectual property estate and an extensive data package of pre-clinical and clinical studies.
Cerevast has assembled a management team with extensive technical, scientific, commercial and regulatory expertise. The company has also assembled a Scientific Advisory Board comprised of globally recognized clinicians, all of whom are leading experts in the field of SonoLysis, ultrasound development and stroke treatment.
The company’s headquarters are located in Redmond, Washington.
|Employees (est.) (Nov 2020)||7|
Cerevast Therapeutics total Funding
Cerevast Therapeutics latest funding size
Time since last funding
|6 years ago|
Cerevast Therapeutics investors
|UT Horizon Fund|
Cerevast Therapeutics has 20 Twitter Followers. The number of followers has increased 2.6% quarter over quarter
When was Cerevast Therapeutics founded?
Cerevast Therapeutics was founded in 2015.
Who are Cerevast Therapeutics key executives?
Cerevast Therapeutics's key executives are Bradford A. Zakes, Travis Rothlisberger and Andrew Leo.
How many employees does Cerevast Therapeutics have?
Cerevast Therapeutics has 7 employees.
Who are Cerevast Therapeutics competitors?
Competitors of Cerevast Therapeutics include Lombard Medical, iSTAR Medical and Heartware International.
Where is Cerevast Therapeutics headquarters?
Cerevast Therapeutics headquarters is located at 12100 NE 195th St #150, Bothell.
Where are Cerevast Therapeutics offices?
Cerevast Therapeutics has an office in Bothell.
How many offices does Cerevast Therapeutics have?
Cerevast Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies